Evidence map›Paper›PMID 27380452›Full record

ArticleThe Journal of organic chemistry2016

Site-Selective Chemoenzymatic Glycosylation of an HIV-1 Polypeptide Antigen with Two Distinct N-Glycans via an Orthogonal Protecting Group Strategy.

Christian Toonstra, Mohammed N Amin, Lai-Xi Wang

Open access · greenAbstract read
In one paragraph

Article in The Journal of organic chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Synthesis of glycopeptides and glycopeptide conjugates.Organic & biomolecular chemistry · 2022
    Review
  3. Article
  4. Article
  5. Article
  6. Chemoenzymatic Synthesis of HIV-1 Glycopeptide Antigens.Methods in molecular biology (Clifton, N.J.) · 2020
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Synthesis of Glycosides by Glycosynthases.Molecules (Basel, Switzerland) · 2017
    Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Christian ToonstraDepartment of Chemistry and Biochemistry, University of Maryland , College Park, Maryland 20742, United States.
Mohammed N AminDepartment of Chemistry and Biochemistry, University of Maryland , College Park, Maryland 20742, United States.
Lai-Xi WangDepartment of Chemistry and Biochemistry, University of Maryland , College Park, Maryland 20742, United States.
University of Maryland, College Park · US

Funding

Covergent Chemoenzymatic Synthesis of Glycopeptides and GlycoproteinsR01GM080374 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI WANG, LAI-XI · 2007 to 2021
$3.9M
Synthetic HIV Vaccine Targeting Glycopeptide Neutralizing EpitopesR01AI113896 · NIAID · UNIV OF MARYLAND, COLLEGE PARK · PI WANG, LAI-XI · 2014 to 2018
$2.3M
Synthetic Variable Domain Glycopeptides for Neutralizing Epitope CharacterizationR21AI101035 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI PAUZA, C. DAVID · 2012 to 2013
$411k
NIAID NIH HHS R01 AI113896NIAID NIH HHS R21 AI101035NIGMS NIH HHS R01 GM080374
6 · The paper itself

Abstract

A convergent chemoenzymatic approach for sequential installation of different N-glycans in a polypeptide is described. The method includes introduction of distinguishably protected GlcNAc-Asn building blocks during automated solid phase peptide synthesis (SPPS), followed by orthogonal deprotection of the GlcNAc primers and site-selective sequential extension of the sugar chains through glycosynthase-catalyzed transglycosylation reactions. It was observed that the protecting groups on one neighboring GlcNAc moiety have an impact on the substrate activity of another GlcNAc acceptor toward some endoglycosynthases in transglycosylation. The usefulness of this synthetic strategy was exemplified by an efficient synthesis of the glycopeptide neutralizing epitope of broadly HIV-neutralizing antibody PG9. The method should be generally applicable for the synthesis of complex glycopeptides carrying multiple different N-glycans.

Indexed as

AntibodiesAntigens, ViralEpitopesGlycopeptidesGlycoside HydrolasesGlycosylationHIV-1Immunoglobulin GMagnetic Resonance SpectroscopyMass SpectrometryPeptidesPolysaccharidesSubstrate SpecificitySugarsSurface Plasmon ResonanceAntibodiesAntigens, ViralEpitopesGlycopeptidesGlycoside HydrolasesImmunoglobulin GPeptidesPolysaccharidesSugars

Identifiers

PMID27380452
PMCPMC5705187
OpenAlexW2464353122

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.